Suppr超能文献

相似文献

1
Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
J Med Virol. 2021 Jul;93(7):4205-4218. doi: 10.1002/jmv.26911. Epub 2021 Mar 18.
2
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
mBio. 2021 Aug 31;12(4):e0097021. doi: 10.1128/mBio.00970-21. Epub 2021 Aug 3.
3
Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges.
Mol Biol Rep. 2021 May;48(5):4667-4675. doi: 10.1007/s11033-021-06390-1. Epub 2021 May 22.
5
Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
J Virol. 2021 Sep 9;95(19):e0086121. doi: 10.1128/JVI.00861-21. Epub 2021 Jun 23.
6
Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.
J Med Virol. 2021 Sep;93(9):5260-5276. doi: 10.1002/jmv.27019. Epub 2021 May 3.
7
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2.
PLoS Pathog. 2021 Jan 19;17(1):e1009212. doi: 10.1371/journal.ppat.1009212. eCollection 2021 Jan.
8
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
10
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.

引用本文的文献

2
Insight into Covid Associated Mucormycosis: A Prospective Study.
Iran J Otorhinolaryngol. 2025;37(1):27-32. doi: 10.22038/ijorl.2024.78990.3662.
5
SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.
Front Microbiol. 2023 Nov 23;14:1320856. doi: 10.3389/fmicb.2023.1320856. eCollection 2023.
6
7
COVID-19: The Ethno-Geographic Perspective of Differential Immunity.
Vaccines (Basel). 2023 Jan 31;11(2):319. doi: 10.3390/vaccines11020319.
8
Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening.
Anal Chem. 2023 Feb 21;95(7):3789-3798. doi: 10.1021/acs.analchem.2c04988. Epub 2023 Feb 8.
9
Small molecules in the treatment of COVID-19.
Signal Transduct Target Ther. 2022 Dec 5;7(1):387. doi: 10.1038/s41392-022-01249-8.

本文引用的文献

3
Predicting the animal hosts of coronaviruses from compositional biases of spike protein and whole genome sequences through machine learning.
PLoS Pathog. 2021 Apr 20;17(4):e1009149. doi: 10.1371/journal.ppat.1009149. eCollection 2021 Apr.
4
Chopping the tail: How preventing superspreading can help to maintain COVID-19 control.
Epidemics. 2021 Mar;34:100430. doi: 10.1016/j.epidem.2020.100430. Epub 2020 Dec 21.
5
Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection.
PLoS Comput Biol. 2020 Dec 8;16(12):e1008461. doi: 10.1371/journal.pcbi.1008461. eCollection 2020 Dec.
6
The impact of lockdown strategies targeting age groups on the burden of COVID-19 in France.
Epidemics. 2020 Dec;33:100424. doi: 10.1016/j.epidem.2020.100424. Epub 2020 Nov 24.
7
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease.
Virol J. 2020 Nov 26;17(1):190. doi: 10.1186/s12985-020-01457-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验